Predictive Value of Pretherapeutic Maximum Standardized Uptake Value (Suv
Aged
Biomarkers
Combined Modality Therapy
Diagnostic Imaging
/ methods
Female
Fluorodeoxyglucose F18
Humans
Hypopharyngeal Neoplasms
/ diagnosis
Kaplan-Meier Estimate
Laryngeal Neoplasms
/ diagnosis
Male
Middle Aged
Multimodal Imaging
/ methods
Neoplasm Staging
Positron Emission Tomography Computed Tomography
Positron-Emission Tomography
/ methods
ROC Curve
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
20 06 2019
20 06 2019
Historique:
received:
13
09
2018
accepted:
07
06
2019
entrez:
22
6
2019
pubmed:
22
6
2019
medline:
22
10
2020
Statut:
epublish
Résumé
The aim of the study was to evaluate whether pretherapeutic metabolic tumor parameters from 18-fluorodeoxyglucose positron emission tomography (FDG-PET) imaging could predict larynx preservation in laryngeal and hypopharyngeal cancer patients prior to primary chemoradiation. Tumor metabolic parameters [maximum standardized uptake value (SUV
Identifiants
pubmed: 31222167
doi: 10.1038/s41598-019-45462-y
pii: 10.1038/s41598-019-45462-y
pmc: PMC6586936
doi:
Substances chimiques
Biomarkers
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
8972Références
Oral Oncol. 2003 Sep;39(6):547-51
pubmed: 12798396
Oral Oncol. 2018 May;80:23-32
pubmed: 29706185
Sci Rep. 2018 Aug 7;8(1):11817
pubmed: 30087375
Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):721-9
pubmed: 25752384
J Laryngol Otol. 2016 Aug;130(8):755-62
pubmed: 27339712
Head Neck. 2019 Apr;41(4):950-958
pubmed: 30561155
J Clin Oncol. 2013 Mar 1;31(7):845-52
pubmed: 23182993
N Engl J Med. 2003 Nov 27;349(22):2091-8
pubmed: 14645636
N Engl J Med. 1991 Jun 13;324(24):1685-90
pubmed: 2034244
Clin Exp Metastasis. 2015 Jan;32(1):55-63
pubmed: 25433796
Crit Rev Oncol Hematol. 2016 Dec;108:40-51
pubmed: 27931839
J Nucl Med. 2014 Jun;55(6):884-90
pubmed: 24752671
Eur Arch Otorhinolaryngol. 2012 Feb;269(2):629-38
pubmed: 21643935
Nat Rev Cancer. 2011 Jun;11(6):393-410
pubmed: 21606941
Ann Oncol. 2007 Oct;18(10):1698-703
pubmed: 17716985
J Nucl Med. 2009 Aug;50(8):1205-13
pubmed: 19617339
Eur J Nucl Med Mol Imaging. 2011 Nov;38(11):2083-95
pubmed: 21853309
Otolaryngol Head Neck Surg. 2016 Mar;154(3):421-32
pubmed: 26715675
J Natl Cancer Inst. 2008 May 21;100(10):712-20
pubmed: 18477804
Nagoya J Med Sci. 2017 Feb;79(1):27-36
pubmed: 28303058
J Pathol Inform. 2016 Jan 29;7:3
pubmed: 26955501
Ann Oncol. 2013 Jan;24(1):208-14
pubmed: 23002280
Ann Surg Oncol. 2016 Jun;23(6):2054-61
pubmed: 26786092
Int J Radiat Oncol Biol Phys. 1997 May 1;38(2):285-9
pubmed: 9226314
Eur J Surg Oncol. 2007 Aug;33(6):790-5
pubmed: 17306956
Top Magn Reson Imaging. 2007 Aug;18(4):243-58
pubmed: 17893590
Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S79-82
pubmed: 17848301
Radiat Res. 2014 Apr;181(4):335-49
pubmed: 24673257
Eur J Cancer. 2017 Feb;72:144-155
pubmed: 28033526
Br J Cancer. 2002 Feb 12;86(4):512-6
pubmed: 11870529
Oncotarget. 2016 Aug 2;7(31):50781-50804
pubmed: 27434126
J Exp Clin Cancer Res. 1999 Mar;18(1):79-83
pubmed: 10374683
J Clin Oncol. 2010 Mar 1;28(7):1190-5
pubmed: 20124179
J Natl Cancer Inst. 1996 Jul 3;88(13):890-9
pubmed: 8656441
Laryngoscope. 2010 May;120(5):937-44
pubmed: 20422687
J Nucl Med. 2004 Sep;45(9):1519-27
pubmed: 15347719
Int J Radiat Oncol Biol Phys. 2015 Jul 1;92(3):594-601
pubmed: 26068492
Head Neck Oncol. 2010 Jul 16;2:19
pubmed: 20637102
Head Neck. 2016 Apr;38 Suppl 1:E1277-80
pubmed: 26514270
Radiother Oncol. 1996 Oct;41(1):31-9
pubmed: 8961365